188 related articles for article (PubMed ID: 28915383)
1. Force-activatable biosensor enables single platelet force mapping directly by fluorescence imaging.
Wang Y; LeVine DN; Gannon M; Zhao Y; Sarkar A; Hoch B; Wang X
Biosens Bioelectron; 2018 Feb; 100():192-200. PubMed ID: 28915383
[TBL] [Abstract][Full Text] [Related]
2. Force-activatable coating enables high-resolution cellular force imaging directly on regular cell culture surfaces.
Sarkar A; Zhao Y; Wang Y; Wang X
Phys Biol; 2018 Jun; 15(6):065002. PubMed ID: 29785968
[TBL] [Abstract][Full Text] [Related]
3. Platelet integrins exhibit anisotropic mechanosensing and harness piconewton forces to mediate platelet aggregation.
Zhang Y; Qiu Y; Blanchard AT; Chang Y; Brockman JM; Ma VP; Lam WA; Salaita K
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):325-330. PubMed ID: 29269394
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
5. Platelet Integrin αIIbβ3 Inhibitor Rescues Progression of Apoptosis in Human Platelets.
Zhu J; Wang Q; Nie Y; Yan R; Dai K; Zhou B
Med Sci Monit; 2016 Nov; 22():4261-4270. PubMed ID: 27827357
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic chip grafted with integrin tension sensors for evaluating the effects of flowing shear stress and ROCK inhibitor on platelets.
Mao S; Sarkar A; Wang Y; Song C; LeVine D; Wang X; Que L
Lab Chip; 2021 Aug; 21(16):3128-3136. PubMed ID: 34180491
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
[TBL] [Abstract][Full Text] [Related]
9. Mapping the 3D orientation of piconewton integrin traction forces.
Brockman JM; Blanchard AT; Pui-Yan V; Derricotte WD; Zhang Y; Fay ME; Lam WA; Evangelista FA; Mattheyses AL; Salaita K
Nat Methods; 2018 Feb; 15(2):115-118. PubMed ID: 29256495
[TBL] [Abstract][Full Text] [Related]
10. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
Jagroop IA; Mikhailidis DP
Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
[TBL] [Abstract][Full Text] [Related]
11. Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model.
Straub A; Azevedo R; Beierlein W; Wendel HP; Dietz K; Ziemer G
Thorac Cardiovasc Surg; 2006 Apr; 54(3):162-7. PubMed ID: 16639676
[TBL] [Abstract][Full Text] [Related]
12. Imaging Integrin Tension and Cellular Force at Submicron Resolution with an Integrative Tension Sensor.
Zhao Y; Wetter NM; Wang X
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31081814
[TBL] [Abstract][Full Text] [Related]
13. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion.
Kupatt C; Wichels R; Horstkotte J; Krombach F; Habazettl H; Boekstegers P
J Leukoc Biol; 2002 Sep; 72(3):455-61. PubMed ID: 12223512
[TBL] [Abstract][Full Text] [Related]
15. High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention.
Walters DL; Ray MJ; Wood P; Perrin EJ; Bett JH; Aroney CN
Eur J Clin Invest; 2010 Feb; 40(2):139-47. PubMed ID: 20039931
[TBL] [Abstract][Full Text] [Related]
16. Programmable Multivalent DNA-Origami Tension Probes for Reporting Cellular Traction Forces.
Dutta PK; Zhang Y; Blanchard AT; Ge C; Rushdi M; Weiss K; Zhu C; Ke Y; Salaita K
Nano Lett; 2018 Aug; 18(8):4803-4811. PubMed ID: 29911385
[TBL] [Abstract][Full Text] [Related]
17. Effects of tirofiban on haemostatic activation in vitro.
Tanaka KA; Katori N; Szlam F; Sato N; Kelly AB; Levy JH
Br J Anaesth; 2004 Aug; 93(2):263-9. PubMed ID: 15194626
[TBL] [Abstract][Full Text] [Related]
18. Integrins outside focal adhesions transmit tensions during stable cell adhesion.
Wang Y; Wang X
Sci Rep; 2016 Nov; 6():36959. PubMed ID: 27845380
[TBL] [Abstract][Full Text] [Related]
19. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
Shimazaki T; Goto S; Sakakibara M; Eto K; Kim JY; Ichikawa N; Yoshida M; Nagaoka Y; Isshiki T; Handa S
J Cardiol; 2000 Aug; 36(2):113-21. PubMed ID: 10955255
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
